Enrolling now! Find out if you are eligible to participate:


Biovie Pharma Refractory Ascites Clinical Research Study

See if you qualify to participate in this clinical trial

If you or a loved one has liver cirrhosis with abdominal fluid, a clinical trial may be an option.

Patients with liver cirrhosis who have refractory ascites (fluid in the abdomen) struggle with ongoing complications that can get worse over time. There is currently no cure for advanced ascites. At this time, there are no prescription therapies specific to the treatment of ascites that have been approved by the US FDA. However, a new investigational treatment may provide a better outlook. If you or a loved one has been diagnosed with refractory ascites, learn more about a clinical trial opportunity today.

Qualified Participants Are:

  • Between 18 and 80 years of age
  • Diagnosed with cirrhosis of the liver
  • Diagnosed with diuretic-resistant ascites (fluid in the abdomen that is not controlled by diuretic medication)

Additional criteria apply

Qualified Participants May:

  • Have access to an investigational treatment option
  • See a doctor or medical staff at no cost
  • Receive compensation for time and travel